Centauri Therapeutics Limited: Centauri Therapeutics Closes £24 Million GBP Series A Investment Round
Investment from Boehringer Ingelheim Venture Fund, Evotec SE, and Novo Holdings REPAIR Impact Fund Funding will support continued advancement of Centauri's antimicrobial resistance research
Source: finanznachrichten.de